In Ph+ CML, the NSG mouse-engrafting LSC reside within a sub-fraction of CD34+/CD38− cells that aberrantly co-express CD25, CD26 and IL-1RAP (Table 4; [72]). The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.